United States Respiratory Devices Market Outlook to 2025

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4995
Buy Report

Published: December 15, 2019 Report Code: GDMECC4564DB-ST

Select Item

“What is covered in the report about the “United States Respiratory Devices Market”?
GlobalData’s “United States Respiratory Devices Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the United States Respiratory Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Humidifiers, Nebulizers, Non-Invasive Ventilation Masks & Circuits, Oxygen Concentrators, Oxygen Conservers, Positive Airway Pressure Devices, Respiratory Device Accessories and Ventilators.

The United States Respiratory Devices Market report provides key information and data on
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2018 company share and distribution share data for Respiratory Devices market.
• Global corporate-level profiles of key companies operating within the United States Respiratory Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

United States Respiratory Devices is segmented as follows:
• Humidifiers
• Nebulizers
• Non-Invasive Ventilation Masks & Circuits
• Oxygen Concentrators
• Oxygen Conservers
• Positive Airway Pressure Devices
• Respiratory Device Accessories
• Ventilators

Key Reasons to Purchase
The United States Respiratory Devices Market report helps you to develop
• Business strategies by identifying the key market segments poised for strong growth in the future.
• Market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “United States Respiratory Devices Market Outlook to 2025” report
• ResMed Inc
• Philips Respironics Inc
• Fisher & Paykel Healthcare Corporation Ltd

The GlobalData Differentiation
Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.
The data and analysis within this report are driven by GlobalData Medical Equipment (GDME) databases. GlobalData Medical Equipment database gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 15,000+ primary interviews, conducted annually to ensure data and report quality
• 3,500+ industry-leading analysis and procedure reports covering growing sectors, market trends, investment opportunities and competitive landscape
• 66.956+ medical equipment company profiles
• 4,300+ company profiles of medical equipment manufacturers in China and India
• 825+ companies’ revenue splits and market shares
• 2,000+ quarterly and annual medical equipment company financials
• 1,100+ medical equipment company SWOTs
• 27,500+ pipeline product profiles
• 55,100+ marketed product profiles
• 46,100+ clinical trials
• 52,400+ trial investigators
• 7,900+ reports on companies with products in development
• 41,700+ deals in the medical equipment industry
For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx

Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

NA

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 8

2 Introduction 9

2.1 What Is This Report About? 9

2.2 Respiratory Devices Market Segmentation 9

2.3 Definitions of Markets Covered in the Report 10

3 Respiratory Devices Market, United States 14

3.1 Respiratory Devices Market, United States, Revenue ($m), 2015-2025 14

3.1.1 Nebulizers Market, United States, Revenue ($m), by Segment, 2015-2025 17

3.1.2 Non-Invasive Ventilation Masks & Circuits Market, United States, Revenue ($m), by Segment, 2015-2025 19

3.1.3 Oxygen Concentrators Market, United States, Revenue ($m), by Segment, 2015-2025 21

3.1.4 Oxygen Conservers Market, United States, Revenue ($m), by Segment, 2015-2025 23

3.1.5 Positive Airway Pressure Devices Market, United States, Revenue ($m), by Segment, 2015-2025 25

3.1.6 Respiratory Device Accessories Market, United States, Revenue ($m), by Segment, 2015-2025 27

3.1.7 Ventilators Market, United States, Revenue ($m), by Segment, 2015-2025 30

3.2 Respiratory Devices Market, United States, Volume (Units), 2015-2025 32

3.2.1 Nebulizers Market, United States, Volume (Units), by Segment, 2015-2025 35

3.2.2 Non-Invasive Ventilation Masks & Circuits Market, United States, Volume (Units), by Segment, 2015-2025 37

3.2.3 Oxygen Concentrators Market, United States, Volume (Units), by Segment, 2015-2025 39

3.2.4 Oxygen Conservers Market, United States, Volume (Units), by Segment, 2015-2025 41

3.2.5 Positive Airway Pressure Devices Market, United States, Volume (Units), by Segment, 2015-2025 43

3.2.6 Respiratory Device Accessories Market, United States, Volume (Units), by Segment, 2015-2025 45

3.2.7 Ventilators Market, United States, Volume (Units), by Segment, 2015-2025 48

3.3 Respiratory Devices Market, United States, Average Price ($), 2015-2025 50

3.4 Respiratory Devices Market, United States, Distribution Share by Revenue ($m), 2018 54

3.5 Respiratory Devices Market, United States, Company Share by Revenue ($m), 2018 55

4 Overview of Key Companies in United States, Respiratory Devices Market 57

4.1 ResMed Inc 57

4.1.1 Company Overview 57

4.2 Fisher & Paykel Healthcare Corporation Ltd 57

4.2.1 Company Overview 57

4.3 Dragerwerk AG & Co KGaA 57

4.3.1 Company Overview 57

4.4 Koninklijke Philips NV 58

4.4.1 Company Overview 58

4.5 Teleflex Inc 58

4.5.1 Company Overview 58

4.6 Inogen Inc 58

4.6.1 Company Overview 58

4.7 Medtronic Plc 58

4.7.1 Company Overview 58

4.8 Invacare Corporation 59

4.8.1 Company Overview 59

4.9 GE Healthcare LLC 59

4.9.1 Company Overview 59

4.10 Intersurgical Ltd. 59

4.10.1 Company Overview 59

4.11 Hamilton Medical AG 59

4.11.1 Company Overview 59

4.12 CAIRE Inc 60

4.12.1 Company Overview 60

4.13 Ambu A/S 60

4.13.1 Company Overview 60

4.14 Smiths Medical 60

4.14.1 Company Overview 60

4.15 GCE Group AB 60

4.15.1 Company Overview 60

4.16 Philips Respironics Inc 61

4.16.1 Company Overview 61

4.17 Vyaire Medical Inc 61

4.17.1 Company Overview 61

4.18 Drive DeVilbiss Healthcare Ltd 61

4.18.1 Company Overview 61

4.19 Maquet Holding BV & Co KG 61

4.19.1 Company Overview 61

4.20 DeVilbiss Healthcare LLC 62

4.20.1 Company Overview 62

5 Respiratory Devices Market Pipeline Products 63

6 Financial Deals Landscape 64

6.1 Acquisition 64

6.1.1 Hillrom to Acquire Breathe Technologies for USD130 Million 64

6.2 Asset Transactions 66

6.2.1 Great Elm DME Acquires Respiratory Assets of Midwest Respiratory Care 66

6.3 Debt Offerings 68

6.3.1 ResMed Raises USD250 Million in Private Placement of

3.24% Notes Due 2026 68

6.3.2 ResMed Raises USD250 Million in Private Placement of

3.45% Notes Due 2029 69

6.3.3 Boston Scientific Raises USD1 Billion in Public Offering of

4.700% Notes Due 2049 70

6.3.4 Boston Scientific Raises USD750 Million in Public Offering of

4.550% Notes Due 2039 72

6.3.5 Boston Scientific Raises USD850 Million in Public Offering of

4.000% Notes Due 2029 74

6.3.6 Boston Scientific Raises USD850 Million in Public Offering of

3.450% Notes Due 2024 76

6.3.7 Boston Scientific Raises USD850 Million in Public Offering of

3.750% Notes Due 2026 78

6.4 Equity Offerings 80

6.4.1 Soleno Therapeutics Raises USD15.4 Million in Public Offering of Shares 80

6.4.2 Vapotherm Prices Public Offering of Shares for USD42 Million 82

6.4.3 Genocea Biosciences Prices Public Offering of Shares for USD36.7 Million 84

6.4.4 Genocea Biosciences Raises USD12 Million in Private Placement of Securities 86

6.5 Merger 87

6.5.1 Salter Labs and SunMed Holdings Merge 87

6.6 Partnerships 88

6.6.1 PExA Enters into Research Agreement with Janssen and University of Gothenburg 88

6.6.2 Circassia Pharma Enters into Licensing Agreement with AIT Therapeutics 89

6.7 Venture Financing 90

6.7.1 Pulmair Medical Raises USD3.65 Million in Venture Financing 90

6.7.2 Breethe Raises USD6 Million in Venture Financing 91

6.7.3 Pulmonx Raises USD65 Million in Venture Financing 92

6.7.4 Nuvaira Raises USD79 Million in Venture Financing 94

6.7.5 CSA Medical Raises USD45.2 Million in Venture Financing 97

6.7.6 ALung Technologies Raises USD5 Million in Venture Financing 98

7 Recent Developments 99

7.1 Corporate Communications 99

7.1.1 Sep 25, 2019: Palo Alto Health Sciences appoints Joseph Perekupka as Chief Commercial Officer 99

7.1.2 Sep 18, 2019: Invacare appoints Julie Beck to Board of Directors 99

7.1.3 Aug 20, 2019: Vaxxilon receives grant to develop new prophylactic vaccine 100

7.1.4 Aug 15, 2019: Electromed names John Erb and Greg Fluet to its Board of Directors 101

7.1.5 Aug 07, 2019: OSI Systems receives $6 million order for patient monitoring solutions 101

7.1.6 Jul 31, 2019: New imaging method is more effective at detecting prostate cancer recurrence than standard scan 101

7.1.7 Jul 31, 2019: Teladoc Health names Health Tech Veteran David Sides as Chief Operating Officer 102

7.1.8 Jun 25, 2019: Teladoc Health names Mala Murthy as Chief Financial Officer 103

7.1.9 May 16, 2019: ResMed elects Jan De Witte to its Board of Directors 103

7.1.10 May 09, 2019: Pulmonx announces hiring of chief financial officer 104

7.1.11 Apr 29, 2019: Soleno Therapeutics names Gwen A. Melincoff to Board of Directors 104

7.1.12 Apr 25, 2019: Electromed names Bud Reeves Vice President of Sales 105

7.1.13 Apr 24, 2019: GE Healthcare joins AMSUS Executive Advisory Board to support improving care across the U.S. Federal health sector 106

7.1.14 Mar 18, 2019: 3M announces new business segments and leadership appointments 106

7.1.15 Mar 08, 2019: Palo Alto Health Sciences obtains DMEPOS accreditation by HQAA 107

7.1.16 Feb 12, 2019: Nuvaira secures funds to develop lung denervation system 107

7.1.17 Feb 06, 2019: 3M leadership announcement 108

7.1.18 Jan 22, 2019: Item 9 Labs appoints medical cannabis executives to advisory board 108

7.1.19 Jan 16, 2019: James Borzi named Vice President, Global Supply Chain (CSCO) for GE Healthcare 109

7.1.20 Jan 07, 2019: Julie A. Shimer Ph.D. joins Masimo’s board of directors 109

7.1.21 Jan 03, 2019: RespireRx Pharmaceuticals names James Sapirstein as executive vice board chairman 110

7.1.22 Dec 17, 2018: Teladoc Health Chief Operating Officer and Chief Financial Officer resigns 110

7.1.23 Dec 10, 2018: Genocea appoints Girish Aakalu, Ph.D., Chief Business Officer 111

7.1.24 Nov 28, 2018: Palo Alto Health Sciences names Christopher S. Lento, MBA as chief commercial officer 111

7.1.25 Nov 20, 2018: ResMed names Harjit Gill to its Board of Directors 112

7.1.26 Nov 20, 2018: Invacare: Update on costs associated with exit or disposal activities 112

7.1.27 Nov 19, 2018: Gentex appoints Brian Walker to board of directors 112

7.2 Financial Announcements 113

7.2.1 Oct 30, 2019: Masimo reports third quarter 2019 financial results 113

7.2.2 Oct 30, 2019: Teladoc Health reports third quarter 2019 results 115

7.2.3 Oct 24, 2019: Genocea provides corporate update and reports third quarter 2019 financial results 116

7.2.4 Oct 24, 2019: UTMD reports financial performance for third quarter and nine months of year 2019 117

7.2.5 Oct 24, 2019: ResMed announces results for the first quarter of fiscal year 2020 118

7.2.6 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 119

7.2.7 Aug 27, 2019: Electromed announces fiscal 2019 fourth quarter and full year financial results 121

7.2.8 Aug 13, 2019: Basilea initiates trial of derazantinib to treat urothelial cancer 122

7.2.9 Aug 07, 2019: Inogen announces second quarter 2019 financial results and updates 2019 guidance 124

7.2.10 Aug 07, 2019: Soleno Therapeutics provides corporate update and reports second quarter 2019 financial results 126

7.2.11 Aug 05, 2019: Invacare reports results for second quarter 2019 127

7.2.12 Jul 31, 2019: Masimo reports second quarter 2019 financial results 130

7.2.13 Jul 31, 2019: Teladoc Health reports second quarter 2019 results 131

7.2.14 Jul 30, 2019: Utah Medical Products reports financial performance for second quarter 2019 131

7.2.15 Jul 29, 2019: Vapotherm reports second quarter 2019 financial results 136

7.2.16 Jul 25, 2019: ResMed announces results for the fourth quarter of fiscal year 2019 137

7.2.17 Jul 25, 2019: Genocea provides corporate update, including second-quarter 2019 financial results 138

7.2.18 Jul 24, 2019: Boston Scientific announces results for second quarter 2019 139

7.2.19 Jul 17, 2019: New implant uses microcurrent to strengthen heart muscle 140

7.2.20 Jun 10, 2019: Menarini Ricerche at the 24th EHA Congress presenting the first in human clinical study of SEL24/MEN1703 142

7.2.21 May 13, 2019: Soleno Therapeutics provides corporate update and reports first quarter 2019 financial results 143

7.2.22 May 07, 2019: Vapotherm reports first quarter 2019 financial results 144

7.2.23 May 07, 2019: Inogen Announces First Quarter 2019 Financial Results and Updates 2019 Guidance 145

7.2.24 May 07, 2019: Electromed announces fiscal 2019 third quarter financial results 147

7.2.25 May 06, 2019: Masimo reports first quarter 2019 financial results 148

7.2.26 May 06, 2019: Invacare reports results for first quarter 2019 149

7.2.27 May 02, 2019: ResMed announces results for the third quarter of fiscal year 2019 150

7.2.28 Apr 30, 2019: Genocea provides corporate update, including first-quarter 2019 financial results 151

7.2.29 Apr 30, 2019: Adherium: Appendix 4C- Quarterly cash flow report to 31 March 2019 152

7.2.30 Apr 25, 2019: 3M reports first-quarter 2019 results; company initiates restructuring 153

7.2.31 Apr 25, 2019: Utah Medical Products reports financial performance for first quarter 2019 155

7.2.32 Apr 24, 2019: Boston Scientific announces results for first quarter 2019 159

7.2.33 Apr 04, 2019: New US patent approval for Episurf Medical 160

7.2.34 Apr 04, 2019: Merrimack Discontinues Development of MM-310 160

7.2.35 Mar 18, 2019: Soleno Therapeutics provides corporate update and reports fourth quarter and full-year 2018 financial results 161

7.2.36 Mar 12, 2019: Vapotherm announces Fourth Quarter and Fiscal Year 2018 Financial Results 163

7.2.37 Feb 28, 2019: Genocea reports fourth quarter 2018 results and announces hiring of new chief financial officer 164

7.2.38 Feb 27, 2019: Teladoc health reports fourth-quarter and full-year 2018 results 165

7.2.39 Feb 26, 2019: Inogen announces fourth quarter and full year 2018 financial results and updates 2019 guidance 166

7.2.40 Feb 26, 2019: Masimo announces fourth quarter and full year 2018 financial results 167

7.2.41 Feb 26, 2019: Masimo reports fourth quarter and full year 2018 financial results 169

7.2.42 Feb 13, 2019: Invacare announces financial results for the fourth quarter and full year ended December 31, 2018 171

7.2.43 Feb 12, 2019: Electromed announces fiscal 2019 second quarter financial results 174

7.2.44 Feb 06, 2019: Boston Scientific announces results for fourth quarter and full year 2018 175

7.2.45 Jan 31, 2019: Adherium: Appendix 4C- Quarterly cash flow report to 31 December 2018 176

7.2.46 Jan 31, 2019: UTMD reports audited year 2018 and fourth quarter financial performance 177

7.2.47 Jan 29, 2019: 3M reports fourth-quarter 2018 results 190

7.2.48 Jan 24, 2019: ResMed announces results for the second quarter of fiscal year 2019 192

7.2.49 Jan 09, 2019: Masimo Announces Select Preliminary Full-Year 2018 Financial Results and 2019 Outlook 193

7.2.50 Jan 08, 2019: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2018 193

7.2.51 Nov 15, 2018: Soleno Therapeutics provides corporate update and reports third quarter 2018 financial results 194

7.2.52 Nov 13, 2018: Electromed announces fiscal 2019 first quarter financial results 195

7.3 Government and Public Interest 197

7.3.1 Sep 05, 2019: Invacare provides business update at Baird Global Healthcare Conference 197

7.3.2 Feb 22, 2019: Propeller Health study finds most asthma patients use inhalers incorrectly 197

7.3.3 Dec 13, 2018: Scientists create most accurate tool yet developed to predict asthma in young children 198

7.3.4 Dec 06, 2018: Reusable Respirators Are an Effective and Viable Option for Protecting Health Care Personnel During Routine Work and Public Health Emergency Response, Says New Report 199

7.4 Legal And Regulatory 200

7.4.1 Sep 30, 2019: Mallinckrodt finalizes settlement to resolve "Track 1" opioid cases with the Ohio Counties of Cuyahoga and Summit 200

7.4.2 Sep 28, 2019: USFDA cGMP inspection completed at Cipla's manufacturing facility in Goa 200

7.4.3 Jun 10, 2019: Cipla: Closure Of USFDA inspection at Kurkumbh Manufacturing Facility 200

7.4.4 May 17, 2019: USFDA post-approval inspection completed at Cipla's Indore manufacturing facility 200

7.4.5 Mar 31, 2019: Cipla: Product specific pre-approval (PAI) and Good Manufacturing Practices (GMP) inspection at its Kurkumbh plant 201

7.4.6 Feb 15, 2019: BRAVO BIDCO: Update on the proposed acquisition of BTG 201

7.4.7 Jan 22, 2019: Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences 201

7.4.8 Jan 15, 2019: Boston Scientific, Edwards Lifesciences agree to global litigation settlement 202

7.5 Other Significant Developments 202

7.5.1 Oct 07, 2019: AstraZeneca launches signature STEM program to empower students to live healthier lives and inspire future scientists 202

7.5.2 Aug 28, 2019: Fisher & Paykel Healthcare upgrades Guidance 202

7.5.3 Aug 28, 2019: Boston Scientific Celebrates 15th Anniversary in Costa Rica 203

7.5.4 Aug 22, 2019: ResMed chooses OneTrust to implement a global privacy program 203

7.5.5 Jul 02, 2019: Invacare announces enhanced transformation plan progress update 204

7.5.6 Jun 07, 2019: GE Healthcare increases multi-vendor parts inventory on its online site to expand offerings 205

7.5.7 May 16, 2019: Children who use asthma tracking app have better disease control and fewer hospital visits 205

7.5.8 Apr 30, 2019: Teladoc health reports first quarter 2019 results 206

7.5.9 Jan 15, 2019: The American Heart Association and Laerdal Medical launch enhanced resuscitation quality improvement portfolio for healthcare 207

7.5.10 Dec 13, 2018: Adherium restructures for growth 208

7.5.11 Dec 06, 2018: HealthStream announces new agreement with RQI Partners, a joint venture between Laerdal Medical and the American Heart Association 208

7.5.12 Nov 15, 2018: Boston Scientific announces global restructuring program 209

7.6 Product News 209

7.6.1 Sep 17, 2019: Veyonda and radiotherapy profiled at key oncology meeting 209

7.6.2 Mar 25, 2019: ResMed launches next-generation ReSupply solution 211

7.6.3 Dec 31, 2018: InventHelp inventor develops comfort accessory for a nasal cannula (CBA-3539) 212

7.6.4 Nov 28, 2018: Aptar Pharma to Showcase Latest Connected Health Innovations and New Active Packaging Technologies at DDL 2018 212

7.7 Strategy And Business Planning 212

7.7.1 Jun 24, 2019: Boston Scientific Galway expands in to new facility 212

7.7.2 Nov 27, 2018: GE Healthcare to open biotechnology manufacturing center in UK 213

8 Appendix 214

8.1 Research Methodology 215

8.1.1 Coverage 215

8.1.2 Secondary Research 215

8.1.3 Primary Research 216

8.1.4 Market Modeling and Forecasting 217

8.1.5 Company Share Analysis 218

8.1.6 Distribution Share Analysis 219

8.1.7 Benchmarking 219

8.2 GlobalData Consulting 220

8.3 Contact Us 220

8.4 Disclaimer 220

Table

1.1 List of Tables

Table 1: Respiratory Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 15

Table 2: Respiratory Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 16

Table 3: Nebulizers Market, United States, Revenue ($m), USD Constant, 2015-2020 18

Table 4: Nebulizers Market, United States, Revenue ($m), USD Constant, 2021-2025 18

Table 5: Non-Invasive Ventilation Masks & Circuits Market, United States, Revenue ($m), USD Constant, 2015-2020 20

Table 6: Non-Invasive Ventilation Masks & Circuits Market, United States, Revenue ($m), USD Constant, 2021-2025 20

Table 7: Oxygen Concentrators Market, United States, Revenue ($m), USD Constant, 2015-2020 22

Table 8: Oxygen Concentrators Market, United States, Revenue ($m), USD Constant, 2021-2025 22

Table 9: Oxygen Conservers Market, United States, Revenue ($m), USD Constant, 2015-2020 24

Table 10: Oxygen Conservers Market, United States, Revenue ($m), USD Constant, 2021-2025 24

Table 11: Positive Airway Pressure Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 26

Table 12: Positive Airway Pressure Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 26

Table 13: Respiratory Device Accessories Market, United States, Revenue ($m), USD Constant, 2015-2020 28

Table 14: Respiratory Device Accessories Market, United States, Revenue ($m), USD Constant, 2021-2025 29

Table 15: Ventilators Market, United States, Revenue ($m), USD Constant, 2015-2020 31

Table 16: Ventilators Market, United States, Revenue ($m), USD Constant, 2021-2025 31

Table 17: Respiratory Devices Market, United States, Volume (Units), 2015-2020 33

Table 18: Respiratory Devices Market, United States, Volume (Units), 2021-2025 34

Table 19: Nebulizers Market, United States, Volume (Units), 2015-2020 36

Table 20: Nebulizers Market, United States, Volume (Units), 2021-2025 36

Table 21: Non-Invasive Ventilation Masks & Circuits Market, United States, Volume (Units), 2015-2020 38

Table 22: Non-Invasive Ventilation Masks & Circuits Market, United States, Volume (Units), 2021-2025 38

Table 23: Oxygen Concentrators Market, United States, Volume (Units), 2015-2020 40

Table 24: Oxygen Concentrators Market, United States, Volume (Units), 2021-2025 40

Table 25: Oxygen Conservers Market, United States, Volume (Units), 2015-2020 42

Table 26: Oxygen Conservers Market, United States, Volume (Units), 2021-2025 42

Table 27: Positive Airway Pressure Devices Market, United States, Volume (Units), 2015-2020 44

Table 28: Positive Airway Pressure Devices Market, United States, Volume (Units), 2021-2025 44

Table 29: Respiratory Device Accessories Market, United States, Volume (Units), 2015-2020 46

Table 30: Respiratory Device Accessories Market, United States, Volume (Units), 2021-2025 47

Table 31: Ventilators Market, United States, Volume (Units), 2015-2020 49

Table 32: Ventilators Market, United States, Volume (Units), 2021-2025 49

Table 33: Respiratory Devices Market, United States, Average Price ($), 2015-2020 50

Table 34: Respiratory Devices Market, United States, Average Price ($), 2021-2025 52

Table 35: Respiratory Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 54

Table 36: Respiratory Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2018 56

Table 37: Respiratory Devices Market Pipeline Products 63

Table 38: Hillrom to Acquire Breathe Technologies for USD130 Million 64

Table 39: Great Elm DME Acquires Respiratory Assets of Midwest Respiratory Care 66

Table 40: ResMed Raises USD250 Million in Private Placement of 3.24% Notes Due 2026 68

Table 41: ResMed Raises USD250 Million in Private Placement of 3.45% Notes Due 2029 69

Table 42: Boston Scientific Raises USD1 Billion in Public Offering of 4.700% Notes Due 2049 70

Table 43: Boston Scientific Raises USD750 Million in Public Offering of 4.550% Notes Due 2039 72

Table 44: Boston Scientific Raises USD850 Million in Public Offering of 4.000% Notes Due 2029 74

Table 45: Boston Scientific Raises USD850 Million in Public Offering of 3.450% Notes Due 2024 76

Table 46: Boston Scientific Raises USD850 Million in Public Offering of 3.750% Notes Due 2026 78

Table 47: Soleno Therapeutics Raises USD15.4 Million in Public Offering of Shares 80

Table 48: Vapotherm Prices Public Offering of Shares for USD42 Million 82

Table 49: Genocea Biosciences Prices Public Offering of Shares for USD36.7 Million 84

Table 50: Genocea Biosciences Raises USD12 Million in Private Placement of Securities 86

Table 51: Salter Labs and SunMed Holdings Merge 87

Table 52: PExA Enters into Research Agreement with Janssen and University of Gothenburg 88

Table 53: Circassia Pharma Enters into Licensing Agreement with AIT Therapeutics 89

Table 54: Pulmair Medical Raises USD3.65 Million in Venture Financing 90

Table 55: Breethe Raises USD6 Million in Venture Financing 91

Table 56: Pulmonx Raises USD65 Million in Venture Financing 92

Table 57: Nuvaira Raises USD79 Million in Venture Financing 94

Table 58: CSA Medical Raises USD45.2 Million in Venture Financing 97

Table 59: ALung Technologies Raises USD5 Million in Venture Financing 98

Table 60: Total Number of Primary Research Participants, Anesthesia and Respiratory Devices Market, by Country 217

Figures

1.2 List of Figures

Figure 1: Respiratory Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 14

Figure 2: Nebulizers Market, United States, Revenue ($m), USD Constant, 2015-2025 17

Figure 3: Non-Invasive Ventilation Masks & Circuits Market, United States, Revenue ($m), USD Constant, 2015-2025 19

Figure 4: Oxygen Concentrators Market, United States, Revenue ($m), USD Constant, 2015-2025 21

Figure 5: Oxygen Conservers Market, United States, Revenue ($m), USD Constant, 2015-2025 23

Figure 6: Positive Airway Pressure Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 25

Figure 7: Respiratory Device Accessories Market, United States, Revenue ($m), USD Constant, 2015-2025 27

Figure 8: Ventilators Market, United States, Revenue ($m), USD Constant, 2015-2025 30

Figure 9: Respiratory Devices Market, United States, Volume (Units), 2015-2025 32

Figure 10: Nebulizers Market, United States, Volume (Units), 2015-2025 35

Figure 11: Non-Invasive Ventilation Masks & Circuits Market, United States, Volume (Units), 2015-2025 37

Figure 12: Oxygen Concentrators Market, United States, Volume (Units), 2015-2025 39

Figure 13: Oxygen Conservers Market, United States, Volume (Units), 2015-2025 41

Figure 14: Positive Airway Pressure Devices Market, United States, Volume (Units), 2015-2025 43

Figure 15: Respiratory Device Accessories Market, United States, Volume (Units), 2015-2025 45

Figure 16: Ventilators Market, United States, Volume (Units), 2015-2025 48

Figure 17: Respiratory Devices Market, United States, Company Share (%) 2018 55

Frequently asked questions

United States Respiratory Devices Market Outlook to 2025 standard reports
Currency USD
$4,995

Can be used by individual purchaser only

Most Popular
$9,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$14,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Anesthesia and Respiratory Devices reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States Respiratory Devices Market Outlook to 2025 in real time.

  • Access a live United States Respiratory Devices Market Outlook to 2025 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more